Clinical Trials Directory

Trials / Unknown

UnknownNCT04932161

Efficacy of Titanium Granules in the Treatment of Periodontal Intrabony Defects

Comparative Efficacy of Titanium Granules Over Hydroxyapatite in the Treatment of Periodontal Intrabony Defects: A Clinico-radiographic Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
SVS Institute of Dental Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The ideal goal of the periodontal treatment is not only to prevent the progression of the disease, but also the regeneration and reconstruction of lost tissues. Many surgical techniques have been used to regenerate intrabony defects (IBD). Titanium stimulates activation of the complement system, surface binding of platelets, and platelet activation as reflected by increased levels of platelet-derived growth factor, which is a substantial promoter of bone growth. Hence we may speculate that using a bone substitute made of titanium may be positive from the perspective of bone formation in osseous defects.

Detailed description

Titanium granules consist of irregular porous granules of commercially pure titanium. The porous properties may lead to ingrowth of newly formed bone.The osseointegrating response to titanium may be the result of the potent activation of the intrinsic coagulation system and the subsequent release of growth factors from platelets.Therefore, the aim of this study is to compare the effect of titanium particles and hydroxyapatite on osseous regeneration in intrabony defects. After reflection of flap and degranulation, bone graft i.e., titanium particles (test group) or hydroxyapatite(control group) will be placed in the void created by the defect and sutures will be placed.

Conditions

Interventions

TypeNameDescription
PROCEDURETitanium GranulesAfter degranulation of the intrabony defect, titanium particles will be placed in the defect and will be sutured.
PROCEDUREHydroxyapatiteAfter degranulation of the intrabony defect, hydroxyapatite will be placed in the defect and will be sutured.

Timeline

Start date
2021-08-01
Primary completion
2022-02-01
Completion
2022-12-01
First posted
2021-06-21
Last updated
2021-06-21

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04932161. Inclusion in this directory is not an endorsement.